1. Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins. (27th August 2018) Authors: Morrow, Marie E; Morgan, Michael T; Clerici, Marcello; Growkova, Katerina; Yan, Ming; Komander, David; Sixma, Titia K; Simicek, Michal; Wolberger, Cynthia Journal: EMBO reports Issue: Volume 19:Number 10(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma. Issue 7 (1st March 2023) Authors: Jelinek, Tomas; Bezdekova, Renata; Zihala, David; Sevcikova, Tereza; Anilkumar Sithara, Anjana; Pospisilova, Lenka; Sevcikova, Sabina; Polackova, Petra; Stork, Martin; Knechtova, Zdenka; Venglar, Ondrej; Kapustova, Veronika; Popkova, Tereza; Muronova, Ludmila; Chyra, Zuzana; Hrdinka, Matous; Simi... Journal: Journal of clinical oncology Issue: Volume 41:Issue 7(2023) Page Start: 1383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination. Issue 3 (8th February 2016) Authors: Baietti, Maria Francesca; Simicek, Michal; Abbasi Asbagh, Layka; Radaelli, Enrico; Lievens, Sam; Crowther, Jonathan; Steklov, Mikhail; Aushev, Vasily N; Martínez García, David; Tavernier, Jan; Sablina, Anna A Journal: EMBO molecular medicine Issue: Volume 8:Issue 3(2016) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Single‐agent venetoclax induces MRD‐negative response in relapsed primary plasma cell leukemia with t(11;14). Issue 1 (25th November 2018) Authors: Jelinek, Tomas; Mihalyova, Jana; Kascak, Michal; Duras, Juraj; Popkova, Tereza; Benkova, Katerina; Richterova, Petra; Plonkova, Hana; Zuchnicka, Jana; Broskevicova, Lucie; Huvarova, Lucie; Cerna, Lucie; Growkova, Katerina; Simicek, Michal; Havel, Martin; Gumulec, Jaromir; Navratil, Milan; Koriste... Journal: American journal of hematology Issue: Volume 94:Issue 1(2019:Jan.) Page Start: E35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Venetoclax plus bortezomib and dexamethasone in heavily pretreated end‐stage myeloma patients without t(11;14): A real‐world cohort. Issue 3 (23rd April 2020) Authors: Jelinek, Tomas; Popkova, Tereza; Duras, Juraj; Mihalyova, Jana; Kascak, Michal; Benkova, Katerina; Plonkova, Hana; Cerna, Lucie; Koristek, Zdenek; Simicek, Michal; Hajek, Roman Journal: Hematological oncology Issue: Volume 38:Issue 3(2020) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗